preloader

CELL THERAPY FOR DEGENERATIVE DISC DISEASE IN MALAYSIA

Unlocking the Potential of Cell-based Therapies Since 2017
CELL THERAPY FOR DEGENERATIVE DISC DISEASE IN MALAYSIA

A pioneer in cell therapy for Degenerative Disc disease, Cyrona Cell's broad and leading cell therapy expertise has transformed the lives of many individuals living with multiple different health conditions.

How Can Cell Therapy Help You?

Cyrona Cell uses Wharton’s Jelly mesenchymal cells that have been derived from infant umbilical cords as they can:

  • Prevent the further deterioration of the nucleus pulposus, the shock absorbers of the spine
  • Recruit hyaluronic acid and proteoglycans to attract and retain more water to hydrate the discs and the nucleus pulposus
  • Prevent scar tissue (fibroids) from forming in the nucleus pulposus
  • Alleviate pain and discomfort
  • Differentiate into chondrocytes, which maintain the cartilaginous tissues within joints
  • Differentiate into the cells that form the nucleus pulposus
  • Modulate the immune system and decrease inflammation to enable the body to heal

 

Cellular Therapy: A Transformation Healthcare Solution

As Degenerative Disc disease occurs due to the failure of the cartilaginous endplates, chondrocytes, and proteoglycans to maintain the structural integrity of the outer casings of discs (the annulus fibrosus), the aim of cell therapy is to facilitate the transportation of nutrients into discs, increase disc height and pressure, prevent chondrocytes from dying, and regenerate the intervertebral discs.

Scientifically-Proven Results

Year

University/Centre

Results

2006

Tokai University School of Medicine, Japan

Increased disc height by 91% and MRI signal intensity by 81%, indicating that water had been attracted to the region.

2011

Centro Médico Teknon, Spain

Decreased pain and disability by 85%.

2014

General Hospital of Armed Police Force, China

Immediate improvement in pain and functionality. Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) remained decreased two years after therapy.

2014

Mesoblast Limited, Australia

Decreased lower back pain and improved functionality for 12 months, decreased dependence on pain medication, increased disc stability, and decreased the need for surgical and non-surgical interventions.

2015

Rocky Mountain Associates in Orthopedic Medicine and the Orthopedic Stem Cell Institute, United States

Decreased Oswestry Disability Index (ODI) and Visual Analog Scale (VAS) scores from 56.5 to 25.0 and 79.3 to 33.2, respectively, for 12 months.

2015

Cha University, South Korea

Significantly increased disc water content in 12 weeks.

2015

Navy General Hospital, China

Significantly improved and halt the progression of disc height reduction as well as promoted the formation of disc matrix components (aggrecan and type II collagen), proteins that are critical for providing discs with structure and support.

 

Why is Cyrona Cell the Right Choice for You?

Achieving high standards in our work is of paramount importance to us. As such, we only produce and use premium grade passage 1 (P1) and passage 2 (P2) Wharton’s Jelly mesenchymal stem cells in all our therapy programmes. These cellular products have also been thoroughly screened and analysed in accordance with the requirements of The International Society for Cellular Therapy prior to use.

We also use the latest in cellular research and technologies to tailor our therapy programmes according to the needs of the individual. Furthermore, our microbiology and clinical team as well as our extensively experienced board-certified physicians are geared towards your safety and wellbeing.

 

 

More than 1000 people are choosing Cyrona Health

 

Start the Journey towards the Best Version of Yourself Today

All our therapy programmes are conducted using premium grade P1 and P2 Wharton’s Jelly mesenchymal cells and by board-certified experienced specialists. All patients are also provided with pre-transfusion analysis reports of any and all cellular and supplementary products used during treatment.

International patients will be provided with airport transfer services and accommodations as well as in-city transportation to and from every therapy session.

 

How Do We Proceed?

As no two people are alike, our specialists review each patient’s medical reports before developing the best treatment protocol to addresses their unique needs. Therefore, before speaking to one of our Customer Service Representatives, it is best to have the following handy:

  • Imaging results (MRI scan / CT scan / X-Ray)
  • Haematology reports (HbA1c blood test)
  • Medical evaluation reports
  • Pictures or videos of the patient (if applicable)

 

Our Facilities

Download a complimentary eBook about Degenerative Disc Disease

Download our eBook and receive our weekly in-depth and exclusive newsletter about Degenerative Disc Disease.

CELL THERAPY FOR DEGENERATIVE DISC DISEASE IN MALAYSIA eBook